Comerica Bank’s VanEck Pharmaceutical ETF PPH Stock Holding History

Comerica Bank’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$102K	Buy	986 +924	+1,490%	+$89.9K	﹤0.01%	2610
2025 Q3	$5.6K	Sell	62 -368	-86%	-$32.2K	﹤0.01%	3376
2025 Q2	$37.8K	Sell	430 -117	-21%	-$10.1K	﹤0.01%	2878
2025 Q1	$49.8K	Buy	547 +90	+20%	+$8.11K	﹤0.01%	2791
2024 Q4	$39.4K	Sell	457 -836	-65%	-$75.6K	﹤0.01%	2865
2024 Q3	$123K	Sell	1,293 -36	-3%	-$3.42K	﹤0.01%	2494
2024 Q2	$122K	Sell	1,329 -8	-0.6%	-$714	﹤0.01%	2462
2024 Q1	$121K	Buy	1,337 +378	+39%	+$33.1K	﹤0.01%	2476
2023 Q4	$78K	Buy	959 +221	+30%	+$17.3K	﹤0.01%	2585
2023 Q3	$58.9K	Buy	+738	New	+$59.5K	﹤0.01%	2659

Other funds holding PPH

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Comerica Bank's PPH Position: Q4 2025 in Review

Comerica Bank increased its VanEck Pharmaceutical ETF (PPH) stake by 1,490% in Q4 2025, buying an estimated $89.9K and bringing the position to 986 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Comerica Bank first reported a position in PPH in Q3 2023 and has held it in 10 quarters since. The position peaked at $123K in Q3 2024. 146 funds tracked by Wall St. Rank hold PPH as of Q4 2025.

Comerica Bank held 986 shares of VanEck Pharmaceutical ETF worth $102K as of Q4 2025.
Comerica Bank bought 924 VanEck Pharmaceutical ETF shares in Q4 2025, an estimated $89.9K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2610 holding.
Comerica Bank first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's VanEck Pharmaceutical ETF position peaked at $123K in Q3 2024.
146 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.